Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 6/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.49 |
| ▸ | HPGD | P15428 | 4/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.49 |
| ▸ | NPC1 | O15118 | 3/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.49 |
| ▸ | MEN1 | O00255 | 2/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.49 |
| ▸ | RAB9A | P51151 | 2/20 | 0.49 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.45 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.45 |
| ▸ | HSP90AB1 | P08238 | 1/20 | 0.45 |
| ▸ | MAOA | P21397 | 3/20 | 0.45 |
| ▸ | MAOB | P27338 | 2/20 | 0.45 |
| ▸ | AHR | P35869 | 2/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
| ▸ | TNKS | O95271 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30513484 | 1.00 | MAPT (0.49) | MAPTALDH1A1HPGDSMN1; SMN2NPC1 | |
| SCHEMBL17875159 | 0.94 | PLA2G2A (0.46) | MAPTALDH1A1HPGDSMN1; SMN2NPC1 | |
| SCHEMBL16491686 | 0.90 | AHR (0.49) | MAPTALDH1A1HPGDSMN1; SMN2NPC1 | |
| SCHEMBL21283017 | 0.87 | MAPT (0.57) | MAPTALDH1A1HPGDSMN1; SMN2NPC1 | |
| SCHEMBL15965728 | 0.85 | MAPT (0.55) | MAPTALDH1A1HPGDSMN1; SMN2NPC1 | |
| SCHEMBL4570805 | 0.85 | MAPT (0.47) | MAPTALDH1A1HPGDSMN1; SMN2NPC1 | |
| SCHEMBL19933761 | 0.84 | HSP90AA1 (0.40) | MAPTALDH1A1HPGDSMN1; SMN2NPC1 | |
| SCHEMBL18731994 | 0.83 | AHR (0.54) | MAPTALDH1A1HPGDSMN1; SMN2NPC1 | |
| SCHEMBL22107192 | 0.83 | ALOX5 (0.61) | MAPTALDH1A1HPGDSMN1; SMN2NPC1 | |
| SCHEMBL18732009 | 0.83 | AHR (0.54) | MAPTALDH1A1HPGDSMN1; SMN2NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 44 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3847167-B1 | ORGANIC MOLECULES FOR OPTOELECTRONIC DEVICES | SAMSUNG DISPLAY CO LTD (KR) | 2025-03-19 | — | — | EP | disclosed |
| WO-2024080655-A1 | COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING SAME, AND ELECTRONIC DEVICE HAVING SAME | 덕산네오룩스 주식회사 | 2024-04-18 | — | — | WO | disclosed |
| CN-110139913-B | Electroluminescent device comprising host compound | 三星显示有限公司 | 2023-07-28 | — | — | CN | disclosed |
| US-20230126850-A1 | HETEROCYCLIC SPIRO COMPOUNDS | MERCK PATENT GMBH (DE) | 2023-04-27 | — | — | US | disclosed |
| US-20230126850-A1 | HETEROCYCLIC SPIRO COMPOUNDS | MERCK PATENT GMBH (DE) | 2023-04-27 | — | — | US | disclosed |
| US-11545634-B2 | Heterocyclic spiro compounds | MERCK PATENT GMBH (DE) | 2023-01-03 | — | — | US | disclosed |
| US-11380850-B2 | Organic electroluminescent devices comprising host compounds | CYNORA GMBH (DE) | 2022-07-05 | — | — | US | disclosed |
| EP-3847167-A1 | ORGANIC MOLECULES FOR OPTOELECTRONIC DEVICES | cynora GmbH (DE) | 2021-07-14 | — | — | EP | disclosed |
| EP-3535347-B1 | ORGANIC ELECTROLUMINESCENT DEVICES COMPRISING HOST COMPOUNDS | CYNORA GMBH (DE) | 2021-03-03 | — | — | EP | disclosed |
| US-10777750-B2 | Heterocyclic spiro compounds | BASF SE (DE) | 2020-09-15 | — | — | US | disclosed |
| US-9461251-B2 | Anthracene derivative and organic electroluminescence device using the same | IDEMITSU KOSAN CO., LTD. (JP) | 2016-10-04 | — | — | US | disclosed |
| US-20160190466-A1 | MATERIALS FOR ELECTRONIC DEVICES | MERCK PATENT GMBH (DE) | 2016-06-30 | — | — | US | disclosed |
| US-20160190466-A1 | MATERIALS FOR ELECTRONIC DEVICES | MERCK PATENT GMBH (DE) | 2016-06-30 | — | — | US | disclosed |
| EP-2163550-B1 | ANTHRACENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME | IDEMITSU KOSAN CO (JP) | 2015-09-09 | — | — | EP | disclosed |
| WO-2015090504-A2 | HETEROCYCLIC SPIRO COMPOUNDS | MERCK PATENT GMBH (DE) | 2015-06-25 | — | — | WO | disclosed |
| WO-2015022051-A1 | MATERIALS FOR ELECTRONIC DEVICES | MERCK PATENT GMBH (DE) | 2015-02-19 | — | — | WO | disclosed |
| US-20130313538-A1 | ANTHRACENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME | SONY CORPORATION (JP) | 2013-11-28 | — | — | US | disclosed |
| US-8512875-B2 | Anthracene derivative and organic electroluminescence device using the same | IDEMITSU KOSAN CO., LTD. (JP) | 2013-08-20 | — | — | US | disclosed |
| EP-2163550-A1 | ANTHRACENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME | Idemitsu Kosan Co., Ltd. (JP) | 2010-03-17 | — | — | EP | disclosed |
| US-20080315754-A1 | ANTHRACENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2008-12-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080315754-A1 | ANTHRACENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME | APRT, ETFA, MLLT3 | MAPT 1133/4885ALDH1A1 50/4885HPGD 2107/4885 |
| US-11545634-B2 | Heterocyclic spiro compounds | NES, KCNC1, HCN4 | MAPT 3089/4885ALDH1A1 383/4885HPGD 736/4885 |
| US-20160190466-A1 | MATERIALS FOR ELECTRONIC DEVICES | SDHB, SDHA, ETFB | MAPT 3702/4885ALDH1A1 150/4885HPGD 467/4885 |
| US-20230126850-A1 | HETEROCYCLIC SPIRO COMPOUNDS | NES, KCNC1, HCN4 | MAPT 3089/4885ALDH1A1 383/4885HPGD 736/4885 |
| US-10777750-B2 | Heterocyclic spiro compounds | NES, KCNC1, HCN4 | MAPT 3089/4885ALDH1A1 383/4885HPGD 736/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.